Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunological studies in cystic fibrosis.

Literature DB >> 708098

Immunological studies in cystic fibrosis.

M W Turner, J O Warner, C R Stokes.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1978 PMID： 708098 PMCID： PMC1545069 DOI： 10.1136/adc.53.8.631

Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791

× No keyword cloud information.

25 in total

1. QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors: J L FAHEY; E M MCKELVEY
Journal: J Immunol Date: 1965-01 Impact factor: 5.422

2. A detailed investigation of circulating IgE levels in a normal population.

Authors: L Nye; T G Merrett; J Landon; R J White
Journal: Clin Allergy Date: 1975-03

3. Predisposing factors and the development of reaginic allergy in infancy.

Authors: J F Soothill; C R Stokes; M W Turner; A P Norman; B Taylor
Journal: Clin Allergy Date: 1976-07

4. HL-A antigen type and small-intestinal disease in dermatitis herpetiformis.

Authors: R L Gebhard; S I Katz; J Marks; S Shuster; R J Trapani
Journal: Lancet Date: 1973-10-06 Impact factor: 79.321

5. H-LA 1 and 8 in childhood coeliac disease.

Authors: A S McNeish; R Nelson; P Mackintosh
Journal: Lancet Date: 1973-03-24 Impact factor: 79.321

6. Letter: Cystic fibrosis and HL-A antigens.

Authors: Z Polymenidis; H Ludwig; M Götz
Journal: Lancet Date: 1973-12-22 Impact factor: 79.321

7. Transient IgA deficiency and pathogenesis of infantile atopy.

Authors: B Taylor; A P Norman; H A Orgel; C R Stokes; M W Turner; J F Soothill
Journal: Lancet Date: 1973-07-21 Impact factor: 79.321

8. Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors: I R Mackay; P J Morris
Journal: Lancet Date: 1972-10-14 Impact factor: 79.321

9. Cystic fibrosis--immunological reactions to A. fumigatus and common allergens.

Authors: C P Warren; E Tai; J C Batten; B J Hutchcroft; J Pepys
Journal: Clin Allergy Date: 1975-03

10. HLA in eczema and hay fever.

Authors: M W Turner; T J Brostoff; R S Wells; C R Stokes; J F Soothill
Journal: Clin Exp Immunol Date: 1977-01 Impact factor: 4.330

12 in total

1. Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease.

Authors: E Dagli; J A Warner; C R Besley; J O Warner
Journal: Arch Dis Child Date: 1992-04 Impact factor: 3.791

2. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.

Authors: S S Pedersen; F Espersen; N Høiby; T Jensen
Journal: J Clin Microbiol Date: 1990-04 Impact factor: 5.948

Immunological studies in cystic fibrosis.

1. QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

2. A detailed investigation of circulating IgE levels in a normal population.

3. Predisposing factors and the development of reaginic allergy in infancy.

4. HL-A antigen type and small-intestinal disease in dermatitis herpetiformis.

5. H-LA 1 and 8 in childhood coeliac disease.

6. Letter: Cystic fibrosis and HL-A antigens.

7. Transient IgA deficiency and pathogenesis of infantile atopy.

8. Association of autoimmune active chronic hepatitis with HL-A1,8.

9. Cystic fibrosis--immunological reactions to A. fumigatus and common allergens.

10. HLA in eczema and hay fever.

1. Raised serum soluble interleukin-2 receptor concentrations in cystic fibrosis patients with and without evidence of lung disease.

2. Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis.

3. Lung abscess in cystic fibrosis.

4. Cell mediated immunity and suppressor T cell function in children with cystic fibrosis.

5. IgG antibodies to Aspergillus fumigatus in cystic fibrosis: a laboratory correlate of disease activity.

Review 6. The relationship between atopy and cystic fibrosis.

7. Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood.

8. Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.

9. Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.

10. Reversible airway obstruction in cystic fibrosis.